Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-018470

Director acquired 634 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ASELAGE STEVE · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-28 Grant or award : show line 1 in the form +634 $15.77 $9,998 32,130 D
Loading xslF345X03/form4.xml…